A 2-year-old boy died in a Florida hospital after a doctor negligently deleted a decimal point in his prescription, resulting ...

Tailoring vitamin D3 doses according to patient needs following a heart attack reduces the risk of a second heart attack by ...

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

Diabetes drugs such as semaglutide already have a reputation for lowering the risk of cardiovascular events in people with ...

In patients with preserved heart function after a heart attack, beta-blockers did not improve outcomes, according to a ...

GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...

Diabetes can lead to kidney failure, cardiovascular disease, stroke, diabetic retinopathy and others. Read on to know ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

Blood-thinning drugs that doctors often prescribe interchangeably after procedures to reopen narrowed heart arteries don’t ...